New Models of Collaboration

Both parties will form the alliance based on risk and benefit sharing principle. This will make full use of both parties’ strengths in terms of technology, personnel and facilities to achieve win-win situation.
The main collaboration details are including but not limited to the following:

1. Higher priority to provide the preclinical services on new drug project
2. Risk-sharing on collaboration on new drug project
3. Joint projects and business promotion
4. Consultation on drug development strategy
5. Research project filing